India Device Master File (DMF) under the Fourth Schedule

1. Key takeaways

The Indian Device Master File (DMF) is prepared under Part II, Appendix II of the Fourth Schedule of the Medical Devices Rules, 2017, and serves as the comprehensive technical vehicle through which the CDSCO assesses a product’s safety and performance. It must cover the product description and intended use, design and manufacturing information, risk analysis (ISO 14971), verification and validation data, clinical or performance evidence, labelling and the instructions for use, and the essential principles conformity checklist. The Device Master File is not mandatory for Class A medical devices.

• The DMF is the core technical dossier for import and manufacturing applications reviewed by the CDSCO.
• Its structure follows the fixed order of Appendix II of the Fourth Schedule, and reviewers read the file in that order.
• Companies that already hold EU technical documentation or FDA 510(k) clearances can reuse most of the underlying content.
• What changes is the arrangement and the chain of argument, not the substance of the evidence.
• The essential principles checklist travels with the DMF and is assessed alongside it, not after it.
• For Class A products, the DMF requirement falls away entirely, which materially changes the cost profile of that route.

2. Legal basis

The obligations surrounding the Device Master File are anchored in specific provisions of the Medical Devices Rules, 2017. The table below sets out each matter, the corresponding legal source, and what that source provides, so that applicants can trace every element of the DMF back to a rule.

3. Expert insights

Insight one: India does not ask you to write a second dossier, but it does ask you to use its format. Companies that have already assembled EU technical documentation or an FDA 510(k) submission can reuse the overwhelming majority of the content — the clinical evaluation report, the risk management documentation, PMS and PMCF records, and the ISO 13485 certificate. What must change is the arrangement and the chain of argument: the CDSCO reads the file in the sequence set out in Appendix II, and a submission that jumps between sections in a different order directly reduces the efficiency of the review. Reformatting an existing dossier into the Appendix II sequence is therefore a real, billable work item, not a formality.

Insight two: the essential principles checklist is a standalone deliverable. It maps each essential principle of safety and performance, item by item, and for every item it must state which standard and which piece of evidence supports conformity. This checklist is the first station for the reviewer, which is precisely why it is also the material most quickly sent back for correction. Treat it as a document in its own right, with its own version control and its own cover references, rather than as an appendix buried inside the DMF. A checklist that merely cites standards without pointing to the underlying evidence adds no review value and invites questions.

Insight three: the Class A exemption from the DMF is an important piece of cost information. For Class A products that are neither sterile nor measuring, the DMF is not mandatory. This makes the economics of the exemption route even more pronounced — it is not only the licence requirement that falls away, but the core technical file as well. Companies with many low-risk SKUs in their portfolio should segment their Indian pipeline by class precisely for this reason.

Insight four: the information inside the DMF must be word-for-word consistent with the other documents. The three elements — product name, model number, and manufacturer address — must be identical across the six documents: the PoA, the FSC, the label, the IFU, the DMF, and the PMF. The CDSCO’s draft import guidance for IVDs lists “consistency of product name, model, and manufacturing address across all documents” as the first item among common non-conformities. A single differing abbreviation between two documents is enough to trigger a deficiency letter.

4. Practical recommendations

When GRZAN prepares an Indian DMF, it closes the project with a six-document consistency check sheet: the four fields — product name, model number, manufacturer name and address, and the distinction between the legal manufacturer and the actual manufacturer — are compared cell by cell across all six documents, and any difference, down to the level of punctuation, is corrected until the wording matches. The exercise takes only half a day, yet it eliminates the single most frequent category of rejection seen in Indian projects.

• Map the existing dossier against the Appendix II sequence before reformatting, so gaps surface early.
• Build the essential principles checklist as a standalone document with explicit standard and evidence references for each item.
• Run the six-document consistency check as a fixed closing step of every submission cycle.
• For Class A projects, confirm the exemption formally in the project plan rather than assuming it.
• Assign one owner for the four consistency fields so that any wording change propagates to all six documents at once.

5. Verification checklist

• □ The DMF has been arranged in the sequence of Part II, Appendix II of the Fourth Schedule
• □ The essential principles checklist maps every item and states the supporting standard
• □ The risk management documentation has been prepared under ISO 14971
• □ Product name, model, and address are identical across the six documents
• □ Class A projects have confirmed that the DMF is not mandatory

Regulatory information verified as of 27 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including India. Our team prepares dossiers to CDSCO expectations, manages SUGAM submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com